Insurance
Home›Insurance›Health Insurance›Co-pays are blocking access to million-dollar cures, r…
Co-pays are blocking access to million-dollar cures, researchers say
A peer-reviewed commentary argues traditional cost-sharing does more harm than good for curative cell and gene therapies
← Newer storyAXA XL names western E&S casualty underwriting managerOlder story →Mid-market employers are flying blind on alternative funding
More like this
Sources
Insurance BusinessCo-pays are blocking access to million-dollar cures, researchers say